Patients with severe aortic stenosis (AoS) often present with acute heart failure and compensation, frequently leading to cardiogenic shock. Transcatheter Aortic Valve Replacement (TAVR) has been recently performed as a bailout treatment in such patients. The aim of our meta-analysis is to compare urgent TAVR with elective procedures. We systematically screened three databases searching for studies comparing urgent vs elective TAVR. Primary endpoint is the 30-days mortality. Secondary endpoints included in-hospital mortality, device success, periprocedural vascular complications, 30-days stroke, 30-days acute kidney injury (AKI), permanent pacemaker implantation (PPM), moderate or severe paravalvular leakage, and 30-days bleeding. Seventeen studies were included, with a total of 84,495 patients. Urgent TAVR was associated with an increased risk for 30-days mortality [Risk Ratio (RR): 2.53, 95% Confidence Intervals (CI): 1.81–3.54)], in-hospital mortality (RR: 2.67, 95% CI: 1.94–3.68), periprocedural vascular complications (RR: 1.91, 95% CI: 1.28–2.85) and AKI (RR: 2.83, 95% CI: 1.93–4.14), compared with elective procedure. No differences were observed in the other secondary endpoints. Urgent TAVR was associated with higher in-hospital and 30-days mortality, possibly driven by the increased incidence of AKI and vascular complications in urgent TAVR. The results highlight the importance of early TAVR in stable AoS patients.
SchweigerMJChawlaKKLotfiA. Severe aortic stenosis: more than an imaging diagnosis. Am J Med. 2022;135:566-571.
2.
NkomoVTGardinJMSkeltonTNGottdienerJSScottCGEnriquez-SaranoM. Burden of valvular heart diseases: a population-based study. Lancet. 2006;368:1005-1011.
3.
CoisneAScottiALatibA, et al.Impact of moderate aortic stenosis on long-term clinical outcomes. JACC Cardiovasc Interv. 2022;15:1664-1674.
4.
KapadiaSRTuzcuEMMakkarRR, et al.Long-term outcomes of inoperable patients with aortic stenosis randomly assigned to transcatheter aortic valve replacement or standard therapy. Circulation2014;130:1483-1492.
5.
PopmaJJDeebGMYakubovSJ, et al.Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706-1715.
6.
LeonMBSmithCRMackMJ, et al.Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609-1620.
7.
VahanianABeyersdorfFPrazF, et al.2021 ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2022;43:561-632.
8.
OttoCMNishimuraRABonowRO, et al.2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the American college of cardiology/American heart association joint committee on clinical practice guidelines. Circulation. 2021;143:e35-e71.
9.
DebryNKonePVincentF, et al.Urgent balloon aortic valvuloplasty in patients with cardiogenic shock related to severe aortic stenosis: time matters. EuroIntervention. 2018;14:e519-e525.
10.
AwadWIIdhreesMBashirM. Is urgent transcatheter aortic valve replacement better than balloon aortic valvuloplasty?J Card Surg. 2021;36:216-218.
11.
BongiovanniDKühlCBleizifferS, et al.Emergency treatment of decompensated aortic stenosis. Heart. 2018;104:23-29.
12.
NashefSAMRoquesFSharplesLD, et al.EuroSCORE II. Eur J Cardio Thorac Surg. 2012;41:734-745.
13.
ElbadawiAElgendyIYMentiasA, et al.Outcomes of urgent versus nonurgent transcatheter aortic valve replacement. Cathet Cardiovasc Interv. 2020;96:189-195.
14.
KhokharAAGianniniFColomboA, et al.Five-year outcomes with transcatheter aortic-valve replacement. N Engl J Med. 2020;383:595-596.
15.
PageMJMcKenzieJEBossuytPM, et al.The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372:n71.
16.
BrookeBSSchwartzTAPawlikTM. MOOSE reporting guidelines for meta-analyses of observational studies. JAMA Surg. 2021;156:787.
17.
KappeteinAPHeadSJGénéreuxP, et al.Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Thorac Cardiovasc Surg. 2013;145:6-23.
18.
SterneJAHernánMAReevesBC, et al.ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
19.
StangA. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603-605.
20.
SteffenJStockerASchererC, et al.Emergency transcatheter aortic valve implantation for acute heart failure due to severe aortic stenosis in critically ill patients with or without cardiogenic shock. Eur Heart J Acute Cardiovasc Care. 2022;11:877-886.
21.
IchiboriYLiJPatelT, et al.Short-term and long-term outcomes of patients undergoing urgent transcatheter aortic valve replacement under a minimalist strategy. J Invasive Cardiol. 2019;31:E30-E36.
EntaYMiyasakaMTaguriM, et al.Patients’ characteristics and mortality in urgent/emergent/salvage transcatheter aortic valve replacement: insight from the OCEAN-TAVI registry. Open Heart. 2020;7:e001467.
24.
KabahiziASheikhASWilliamsT, et al.Elective versus urgent in-hospital transcatheter aortic valve implantation. Cathet Cardiovasc Interv. 2021;98:170-175.
25.
KaewkesDOchiaiTFlintN, et al.Transcatheter aortic valve implantation in patients with severe aortic stenosis hospitalized with acute heart failure. Am J Cardiol. 2021;144:100-110.
26.
KitaharaHKumamaruHKohsakaS, et al.Clinical outcomes of urgent or emergency transcatheter aortic valve implantation ― insights from the nationwide registry of Japan transcatheter valve therapies. Circ J. 2022;88:CJ220536.
27.
LandesUOrvinKCodnerP, et al.Urgent transcatheter aortic valve implantation in patients with severe aortic stenosis and acute heart failure: procedural and 30-day outcomes. Can J Cardiol. 2016;32:726-731.
28.
CasteloATeixeiraBGrazinaA, et al.Urgent versus non-urgent transcatheter aortic valve implantation outcomes. Cardiology. 2023;148:469-477.
29.
Elbaz-GreenerGYarrantonBQiuF, et al.Association between wait time for transcatheter aortic valve replacement and early postprocedural outcomes. J Am Heart Assoc. 2019;8:e010407. doi:10.1161/JAHA.118.010407.
30.
BiancoVHabertheuerAKilicA, et al.Urgent transcatheter aortic valve replacement may be performed with acceptable long‐term outcomes. J Card Surg. 2021;36:206-215.
31.
AmgaiBPatelNChakrabortyS, et al.30-day readmission following urgent and elective transcatheter aortic valve replacement: a Nationwide Readmission Database analysis. Cathet Cardiovasc Interv. 2021; 98:E1026-E1032. doi:10.1002/ccd.29918.
32.
AngerasOPeturssonPGabelJ, et al.P3295Short and long term prognosis of patients undergoing urgent TAVI. Eur Heart J. 2017; 38:ehx504.P3295. doi:10.1093/eurheartj/ehx504.P3295.
33.
ChenKPolcariKMichikoT, et al.Outcomes of urgent transcatheter aortic valve replacement in patients with acute decompensated heart failure: a single-center experience. Cureus. 2020;12:e10425. doi:10.7759/cureus.10425.
34.
FrerkerCSchewelJSchlüterM, et al.Emergency transcatheter aortic valve replacement in patients with cardiogenic shock due to acutely decompensated aortic stenosis. EuroIntervention. 2016;11:1530-1536.
35.
LuxAVeenstraLFKatsS, et al.Urgent transcatheter aortic valve implantation in an all-comer population: a single-centre experience. BMC Cardiovasc Disord. 2021;21:550.
36.
KolteDKheraSVemulapalliS, et al.Outcomes following urgent/emergent transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2018;11:1175-1185.
37.
HimbertDVahanianA. Transcatheter aortic valve replacement for patients with heart failure. Heart Fail Clin. 2015;11:231-242.
38.
GuptaTGoelKKolteD, et al.Association of chronic kidney disease with in-hospital outcomes of transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10:2050-2060.
39.
HansenJWFoyAYadavP, et al.Death and dialysis after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2017;10:2064-2075.
40.
RangaswamiJBhallaVBlairJEA, et al.Cardiorenal syndrome: classification, pathophysiology, diagnosis, and treatment strategies: a scientific statement from the American heart association. Circulation. 2019;139;e840-e878. doi:10.1161/CIR.0000000000000664.
41.
RiveraFBAl-AbchaAAnsayMFM, et al.Transcatheter aortic valve replacement-associated acute kidney injury: an update. Cardiorenal Med. 2023;13:143-157.
42.
CastriotaFNerlaRMicariASqueriACremonesiA. Contrast-zero transcatheter aortic valve replacement for patients with severe renal dysfunction. JACC Cardiovasc Interv. 2018;11:820-822.
43.
SherwoodMWXiangKMatsouakaR, et al.Incidence, temporal trends, and associated outcomes of vascular and bleeding complications in patients undergoing transfemoral transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2020;13:e008227. doi:10.1161/CIRCINTERVENTIONS.119.008227.
44.
KatsarosOApostolosAKtenopoulosN, et al.Transcatheter aortic valve implantation access sites: same goals, distinct aspects, various merits and demerits. J Cardiovasc Dev Dis. 2023;11:4.
45.
GuedeneyPMehranR. Non-femoral TAVR: time to stratify alternative vascular approaches. Cathet Cardiovasc Interv. 2018;92:1194-1195.
46.
UeshimaDBarioliANaiFL, et al.The impact of pre-existing peripheral artery disease on transcatheter aortic valve implantation outcomes: a systematic review and meta-analysis. Cathet Cardiovasc Interv. 2020;95:993-1000.
47.
AlsaraOAlsarahALaird-FickH. Advanced age and the clinical outcomes of transcatheter aortic valve implantation. J Geriatr Cardiol. 2014;11:163-170.
48.
AnconaMBToscanoEMoroniF, et al.Patients younger than 70 undergoing transcatheter aortic valve implantation: Procedural outcomes and mid-term survival. IJC Hear Vasculature. 2021;34:100817
49.
NagaoKTaniguchiTMorimotoT, et al.Acute heart failure in patients with severe aortic stenosis ― insights from the CURRENT AS registry. Circ J. 2018;82:874-885.
50.
GénéreuxPPibarotPRedforsB, et al.Staging classification of aortic stenosis based on the extent of cardiac damage. Eur Heart J. 2017;38:3351-3358.
51.
ChioncelOParissisJMebazaaA, et al.Epidemiology, pathophysiology and contemporary management of cardiogenic shock – a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2020;22:1315-1341.
MuradMHMontoriVMIoannidisJPA, et al.How to read a systematic review and meta-analysis and apply the results to patient care. JAMA. 2014;312:171.
Supplementary Material
Please find the following supplemental material available below.
For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.
For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.
